Directors Shareholding(s)

Cambridge Antibody Tech Group PLC 4 December 2000 Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: James Foght 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 7 Number of shares/amount of stock acquired: 163 8 Percentage of issued class: 0.00046% 9 Number of shares/amount of stock disposed: n/a 10 Percentage of issued class: n/a 11 Class of security: 10p ordinary shares 12 Price per share: £30.54 13 Date of transaction: 1 December 2000 14 Date company informed: 1 December 2000 15 Total holding following this notification: 163 16 Total percentage holding of issued class following this notification: 0.00046% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 262233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Aaron Klug 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 7 Number of shares/amount of stock acquired: 163 8 Percentage of issued class: 0.00046% 9 Number of shares/amount of stock disposed: n/a 10 Percentage of issued class: n/a 11 Class of security: 10p ordinary shares 12 Price per share: £30.54 13 Date of transaction: 1 December 2000 14 Date company informed: 1 December 2000 15 Total holding following this notification: 28,220 16 Total percentage holding of issued class following this notification: 0.08% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: John Stocker 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 7 Number of shares/amount of stock acquired: 163 8 Percentage of issued class: 0.0046% 9 Number of shares/amount of stock disposed: n/a 10 Percentage of issued class: n/a 11 Class of security: 10p ordinary shares 12 Price per share: £30.54 13 Date of transaction: 1 December 2000 14 Date company informed: 1 December 2000 15 Total holding following this notification: 3,292 16 Total percentage holding of issued class following this notification: 0.0094% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Uwe Bicker 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 7 Number of shares/amount of stock acquired: 163 8 Percentage of issued class: 0.00046 9 Number of shares/amount of stock disposed: n/a 10 Percentage of issued class: n/a 11 Class of security: 10p ordinary shares 12 Price per share: £30.54 13 Date of transaction: 1 December 2000 14 Date company informed: 1 December 2000 15 Total holding following this notification: 2,151 16 Total percentage holding of issued class following this notification: 0.006% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Paul Nicholson 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 7 Number of shares/amount of stock acquired: 163 8 Percentage of issued class: 0.00046% 9 Number of shares/amount of stock disposed: n/a 10 Percentage of issued class: n/a 11 Class of security: 10p ordinary shares 12 Price per share: £30.54 13 Date of transaction: 1 December 2000 14 Date company informed: 1 December 2000 15 Total holding following this notification: 4,434 16 Total percentage holding of issued class following this notification: 0.0126% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Company Secretary Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Peter Garland 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: 7 Number of shares/amount of stock acquired: 327 8 Percentage of issued class: 0.00093% 9 Number of shares/amount of stock disposed: n/a 10 Percentage of issued class: n/a 11 Class of security: 10p ordinary shares 12 Price per share: £30.54 13 Date of transaction: 1 December 2000 14 Date company informed: 1 December 2000 15 Total holding following this notification: 49,827 16 Total percentage holding of issued class following this notification: 0.14% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 017630263233 25 Name of company official responsible for making notification: Company Secretary Additional Information:
UK 100

Latest directors dealings